Former CEO of MetroPlus Health Plan, Dr. Arnold Saperstein, Joins Cecelia Health as Chief Medical Officer

Share Article

Saperstein’s population health and value-based care experience will help Cecelia Health transform lives and health outcomes.

Dr. Arnold Saperstein named CMO of Cecelia Health

Cecelia Health, a leading technology-enabled chronic disease management company based in New York City, has hired former President and CEO of MetroPlus Health Plan, Arnold Saperstein MD, FACP, as Chief Medical Officer. Saperstein began his career in managed care in 1992 and joined MetroPlus Health Plan in 1995 initially as Chief Medical Officer and then as President and CEO from 2006 until 2019. MetroPlus Health Plan, a wholly-owned subsidiary of the New York City Health + Hospitals is a managed care organization that, under Saperstein’s leadership grew from 40,000 members to over 500,000 members with an estimated 32,000 participating providers.

“I am excited and energized to join Cecelia Health to help advance the important work they’re doing to transform lives and outcomes. Providing access to high quality care regardless of geography is a top priority for Cecelia Health. I’m looking forward to launching and managing our virtual diabetes and mental health specialty clinic to enhance the level of care we can provide to the people we serve,” said Saperstein.

Saperstein has spent the majority of his career developing programs that ensure the highest quality of care. During his tenure at MetroPlus, it ranked as one of the highest scoring plans for quality of care as measured by the New York State Department of Health Medicaid Incentive Program and by the Medicaid Consumer Guide for New York City. Under his leadership, MetroPlus rose to the forefront of Value Based Purchasing. Programs he developed included groundbreaking quality incentive pay for performance programs across the entire MetroPlus network.

Dr. Saperstein will play a key role in expanding the services that Cecelia Health delivers to its customers across the pharmaceutical, medical device and health plan market segments. These services include the national rollout of diabetes and related mental health tele-medicine and innovative digital health solutions.

“We are thrilled to welcome Dr. Saperstein to the Cecelia Health team,” says David Weingard, CEO of Cecelia Health. “His extensive experience in population health and management of large networks in a managed care environment will significantly advance our ability to innovate and positively transform the lives and health outcomes of the people we serve.”

About Cecelia Health
Cecelia Health's mission is to positively transform the lives of people living with chronic diseases. Cecelia Health's expert clinicians use Cecelia Health's proprietary technology-enabled personalized coaching solution to optimize health outcomes at a low cost per patient and provide unique data-driven insights to health plans and ACOs seeking to improve quality measures, and pharmaceutical and medical device companies seeking to improve adherence. Cecelia Health has also engaged in numerous joint initiatives with the Juvenile Diabetes Research Foundation, American Diabetes Association, the Diabetes Research Institute, the American Association of Diabetes Educators, the Jaeb Center for Health Research and the Helmsley Charitable Trust.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Robert Lande

Fabiana Rea
Visit website